BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4177921)

  • 1. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
    Matthews AE; Clarke JE
    J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility control with 15-8-5.
    Andelman MB
    Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and morphological studies on hormonal contraception with the sequential method].
    Fettig O; Kopecky P
    Geburtshilfe Frauenheilkd; 1968 Jun; 28(6):540-53. PubMed ID: 4098858
    [No Abstract]   [Full Text] [Related]  

  • 4. Two thousand woman-years' experience with a sequential contraceptive. A more effective method of taking a sequential contraceptive.
    Karrer MC; Smith ER
    Am J Obstet Gynecol; 1968 Dec; 102(7):1029-34. PubMed ID: 4177693
    [No Abstract]   [Full Text] [Related]  

  • 5. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 6. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
    Sawasaki C; Ashitaka Y
    J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysmenorrhoea unrelieved by an oral contraceptive.
    Practitioner; 1968 Jun; 200(200):856-9. PubMed ID: 4871666
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral contraception and gynecologic therapy].
    Käsemann W
    Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary dysmenorrhea: combination vs sequential therapy.
    Buttram VC; Kaufman RH
    Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
    Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
    Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
    [No Abstract]   [Full Text] [Related]  

  • 13. [Normal sequential treatment. experiences with an 11:10 variant of the sequential method for contraception and for medical indications].
    Schmidt H; Langner A; Kaiser R
    Munch Med Wochenschr; 1970 Oct; 112(42):1903-13. PubMed ID: 4097638
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
    Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
    Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dysmenorrhoea with dydrogesterone. Results of a double blind trial.
    Schellen AM; Wesselius de Casparis A
    Bull Soc R Belge Gynecol Obstet; 1967; 37(4):273-6. PubMed ID: 4898824
    [No Abstract]   [Full Text] [Related]  

  • 16. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of dysmenorrhea].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of the hormonal effect of ovosiston in various dosages].
    Kühndel K; Ebeling K; Rothe K
    Z Arztl Fortbild (Jena); 1971 Jan; 65(2):79-84. PubMed ID: 4104626
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
    Müller R; Kempf HJ; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovanon. A new sequential oral contraceptive.
    Rice-Wray E; Peña A; Maqueo M
    Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.